HK1012339A1 - 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives - Google Patents

2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives

Info

Publication number
HK1012339A1
HK1012339A1 HK98113443A HK98113443A HK1012339A1 HK 1012339 A1 HK1012339 A1 HK 1012339A1 HK 98113443 A HK98113443 A HK 98113443A HK 98113443 A HK98113443 A HK 98113443A HK 1012339 A1 HK1012339 A1 HK 1012339A1
Authority
HK
Hong Kong
Prior art keywords
purin
dihydro
oxo
methoxy
amino
Prior art date
Application number
HK98113443A
Other languages
English (en)
Inventor
John J Nestor
Scott W Womble
Hans Maag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1012339(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1012339A1 publication Critical patent/HK1012339A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
HK98113443A 1994-07-28 1998-12-15 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives HK1012339A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28189394A 1994-07-28 1994-07-28

Publications (1)

Publication Number Publication Date
HK1012339A1 true HK1012339A1 (en) 1999-07-30

Family

ID=23079211

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113443A HK1012339A1 (en) 1994-07-28 1998-12-15 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives

Country Status (33)

Country Link
EP (1) EP0694547B1 (el)
JP (1) JP3090305B2 (el)
KR (1) KR100358626B1 (el)
CN (1) CN1045089C (el)
AT (1) ATE179173T1 (el)
AU (1) AU697107B2 (el)
BR (1) BR9503468A (el)
CA (1) CA2154721C (el)
CO (1) CO4410181A1 (el)
CY (2) CY2180B1 (el)
CZ (1) CZ290511B6 (el)
DE (3) DE69509173T2 (el)
DK (1) DK0694547T3 (el)
ES (1) ES2083348T3 (el)
FI (1) FI112080B (el)
GR (2) GR960300021T1 (el)
HK (1) HK1012339A1 (el)
HU (1) HU216867B (el)
IL (1) IL114735A (el)
LU (1) LU91136I2 (el)
MA (1) MA23631A1 (el)
MY (1) MY114393A (el)
NL (1) NL300071I2 (el)
NO (2) NO312899B1 (el)
NZ (1) NZ272652A (el)
PE (1) PE32296A1 (el)
PL (1) PL180609B1 (el)
RU (1) RU2133749C1 (el)
SA (1) SA95160158B1 (el)
TR (1) TR199500895A2 (el)
TW (1) TW434242B (el)
UY (1) UY24006A1 (el)
ZA (1) ZA956228B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
ES2180923T5 (es) * 1996-01-26 2005-10-16 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de purina.
AU1592897A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
CA2277151C (en) * 1997-02-10 2007-04-17 Medivir Ab Synthesis of acyclic nucleoside derivatives
JP3844654B2 (ja) * 1997-08-15 2006-11-15 メディヴィル・アクチボラグ レトロウイルス逆転写酵素およびｂ型肝炎ウイルス（ｈｂｖ）のｄｎａポリメラーゼのインヒビターを含む抗ウイルス剤などのヌクレオシドアナログ
AU1711599A (en) * 1997-12-19 1999-07-12 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
EP1834947A3 (en) * 2002-04-23 2008-05-28 Aventis Pharmaceuticals, Inc. 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors
EP1552833B1 (en) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Process for producing an amorphous optically active isomer of lansoprazole
DK1583542T3 (da) 2003-01-14 2008-09-22 Gilead Sciences Inc Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
BRPI0413331A (pt) * 2003-08-28 2006-10-10 Ranbaxy Lab Ltd cloridrato de valganciclovir amorfo, composição farmacêutica contendo o mesmo e processo para sua preparação
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
US7605123B2 (en) * 2004-07-19 2009-10-20 Biocon Ltd. Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
MY153062A (en) 2007-10-12 2014-12-31 Takeda Pharmaceuticals Usa Inc Methods of treating gastrointestinal disorders independent of the intake of food
CN103562207B (zh) * 2011-05-31 2016-08-17 法尔玛赞公司 用于制备缬更昔洛韦的2-氨基-9-((2-苯基-1，3-二噁烷-5-基氧基)甲基)-1h-嘌呤-6(9h)-酮化合物的制备方法
KR102312533B1 (ko) 2021-02-24 2021-10-15 주식회사 이웅 자동 스패너

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
NO172183C (no) * 1984-12-12 1993-06-16 Syntex Inc Fremgangsmaate for fremstilling av derivater av 9-(1,3-dikydroksy-2-propoksymetyl)-guanin
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
DE10299039I1 (de) * 1988-12-19 2003-02-20 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Praeparte

Also Published As

Publication number Publication date
NL300071I2 (nl) 2002-03-01
PL180609B1 (pl) 2001-03-30
DE69509173T2 (de) 1999-10-21
DE694547T1 (de) 1996-10-24
DE69509173D1 (de) 1999-05-27
CA2154721A1 (en) 1996-01-29
TR199500895A2 (tr) 1996-06-21
ZA956228B (en) 1996-02-22
HU9502238D0 (en) 1995-09-28
KR100358626B1 (ko) 2003-01-14
FI953592A (fi) 1996-01-29
HU216867B (hu) 1999-09-28
RU95113148A (ru) 1997-06-27
MA23631A1 (fr) 1996-04-01
LU91136I2 (fr) 2005-07-06
ES2083348T1 (es) 1996-04-16
AU2719595A (en) 1996-02-08
CZ193995A3 (en) 1996-02-14
MY114393A (en) 2002-10-31
DE10299032I2 (de) 2006-06-14
KR960004345A (ko) 1996-02-23
RU2133749C1 (ru) 1999-07-27
FI953592A0 (fi) 1995-07-27
CO4410181A1 (es) 1997-01-09
ES2083348T3 (es) 1999-08-01
CY2004003I2 (el) 2009-11-04
PL309812A1 (en) 1996-02-05
CN1122804A (zh) 1996-05-22
FI112080B (fi) 2003-10-31
AU697107B2 (en) 1998-09-24
NO952977L (no) 1996-01-29
SA95160158B1 (ar) 2006-05-20
PE32296A1 (es) 1996-08-07
EP0694547B1 (en) 1999-04-21
NO952977D0 (no) 1995-07-27
NL300071I1 (nl) 2002-02-01
JP3090305B2 (ja) 2000-09-18
CZ290511B6 (cs) 2002-08-14
ATE179173T1 (de) 1999-05-15
DK0694547T3 (da) 2000-01-03
CY2004003I1 (el) 2009-11-04
TW434242B (en) 2001-05-16
NO2003001I2 (no) 2007-06-11
BR9503468A (pt) 1996-02-27
DE10299032I1 (de) 2003-01-23
CN1045089C (zh) 1999-09-15
IL114735A0 (en) 1995-11-27
GR960300021T1 (en) 1996-04-30
EP0694547A3 (en) 1996-06-05
HUT73246A (en) 1996-07-29
NO312899B1 (no) 2002-07-15
NZ272652A (en) 1996-12-20
GR3030678T3 (en) 1999-11-30
JPH0841061A (ja) 1996-02-13
UY24006A1 (es) 2001-07-31
IL114735A (en) 1998-06-15
CA2154721C (en) 2001-01-02
CY2180B1 (en) 2002-08-23
EP0694547A2 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
HK1012339A1 (en) 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivatives
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
FI914928A (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
EP0386675A3 (en) Xanthine derivatives
CA2244680A1 (en) Process for preparing purine derivatives
ATE172985T1 (de) Sulfonamidaminomethylenderivate als immunsuppressiva
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ATE145918T1 (de) Monoquaternäre 2,16- bispiperidinglandrostanderivate
SG32424A1 (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivative
LT2417B (lt) Mo budas vaiku astrios leukozes nepalankios eigos isaiskini
AU8803091A (en) Method for protecting the myocardium against ischemia

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150718